Corvita in takeover talks:
This article was originally published in Clinica
Executive Summary
Corvita, a developer of synthetic vascular grafts, is in discussions to be acquired by an unnamed company for around $10 a share. It is also holding discussions about a strategic alliance, the Florida-based company says. The statement came after the share price had risen to $10.63 by January 17th. In November 1994, Corvita floated at $5 a share.